By Debdeep Gupta | 15 Sep, 2025
Alembic Pharma shares gain on EIR from USFDA for Panelav unit
Alembic Pharmaceuticals share price rose in the opening trade on September 15 following the company received establishment inspection report (EIR) post inspection by the US Food and Drug Administration (USFDA).At 09:20am, Alembic Pharmaceuticals was quoting at Rs 953.90, up Rs 8.10, or 0.86 percent, on the BSE.".... has EIR today for the inspection carried out conducted from 26th May, 2025 to 31st...
Live Comments
ProfitGainer01 2025-02-20 09:23:14
The Board of Directors of the Company at its meeting held on 10th February 2025 had declared Second Interim Dividend of Rs. 23/- per equity share of Rs.10/- each (230%) for the financial year ending 31st March 2025 resulting in an outflow of Rs. 35,40,39,460/- (subject to deduction of tax at source where applicable). The said Second Interim Dividend declared by the ESAB India would be paid to the equity shareholders on or before 7th March 2025, as per the company
Login & Reply Like(0) Dislike(0) Repost SpamWorld_Investor1 2022-09-06 12:22:54
buy...hurry...3750 sure shot...4000 possible today
Login & Reply Like(0) Dislike(0) Repost Spam